Portolan Capital Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-208,807
Closed -$7.11M 151
2022
Q3
$7.11M Buy
+208,807
New +$7.72M 0.75% 48

Other funds holding PRVA

Portolan Capital Management's PRVA Position: Q4 2022 in Review

Portolan Capital Management sold out of Privia Health (PRVA) in Q4 2022, closing a stake of 208,807 shares — an estimated $7.11M sold.

Portolan Capital Management first reported a position in PRVA in Q3 2022 and held it in 1 quarter. The position peaked at $7.11M in Q3 2022. 192 funds tracked by Wall St. Rank hold PRVA as of Q4 2022.

  • Portolan Capital Management reported no remaining Privia Health position as of Q4 2022 after selling out during the quarter.
  • Portolan Capital Management sold 208,807 Privia Health shares in Q4 2022, an estimated $7.11M.
  • Portolan Capital Management first reported a position in Privia Health in Q3 2022 and held it in 1 quarter.
  • Portolan Capital Management's Privia Health position peaked at $7.11M in Q3 2022.
  • 192 funds tracked by Wall St. Rank held Privia Health as of Q4 2022.

Based on Portolan Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.